vimarsana.com

TransMedics shines with Q1 EPS at $0.35, and sales soared to $96.9 million. Fiscal 2024 revenue outlook raised to $390 million-$400 million. Analysts hail TransMedics' organic growth and strong market position, praising its innovative solutions and promising prospects.

Related Keywords

William Blair ,National Organ Program ,International Society For Heart ,Transmedics Group Inc ,Transmedics Group ,Organ Care System ,International Society ,Lung Transplantation ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.